Sorafenib in advanced hepatocellular carcinoma: hypertension as a potential surrogate marker for efficacy (Q39622973)

From Wikidata
Jump to navigation Jump to search
scientific article published on August 2013
edit
Language Label Description Also known as
English
Sorafenib in advanced hepatocellular carcinoma: hypertension as a potential surrogate marker for efficacy
scientific article published on August 2013

    Statements

    Sorafenib in advanced hepatocellular carcinoma: hypertension as a potential surrogate marker for efficacy (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit